Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

DNA and RNA Therapeutics: Unsolved Riddles

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Plescia, O. and Braun, W. 1968 Nucleicacids in Immunology. Springer-Verlag, New York.

    Google Scholar 

  2. Messina, J., Gilkeson, G. and Pisetsky, D. 1991. Stimulation of in vitro murine lymphocyte proliferation by bacterial DNA. J. Immunol. 147: 1759–1764.

    CAS  PubMed  Google Scholar 

  3. Urowitz, M., Bookman, A., Koehler, B., Gordon, D., Smythe, H. and Ogryzlo, M. 1976 The bimodal mortality pattern of systemic lupus erythematosus. Am. J. Med. 60: 221–225.

    Article  CAS  Google Scholar 

  4. Stollar, D., Levine, L. and Marmur, J. 1962. Antibodies to denatured deoxyribonucleic acid in lupus erythematosus serum. Biochimica et Biophysica Acta 61: 7–18.

    CAS  PubMed  Google Scholar 

  5. Emlen, W., Holers, M., Arend, W. and Kotzin, B. 1992. Regulation of nuclear antigen expression on the cell surface of human monocytes. J Immunol. 148: 3042–3048.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Edgington, S. DNA and RNA Therapeutics: Unsolved Riddles. Nat Biotechnol 10, 993–994 (1992). https://doi.org/10.1038/nbt0992-993

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0992-993

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing